WBA provides supplemental merger proxy disclosures to address shareholder litigation ahead of July 11 vote

Walgreens Boots Alliance, Inc.

Company filed supplemental disclosures to Definitive Proxy Statement for special meeting on July 11, 2025.
Disclosures add details on financial projections, analyst valuation ranges ($4.60-$12.70 per share implied), and advisor relationships.
Two shareholder lawsuits and 11 demand letters alleged omissions in proxy; company denies merit but voluntarily supplements.
Supplemental disclosures include details on discount rates, risk adjustments, and selected company analysis.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.